[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU1785599A - Novel pyrimidine derivatives - Google Patents

Novel pyrimidine derivatives

Info

Publication number
AU1785599A
AU1785599A AU17855/99A AU1785599A AU1785599A AU 1785599 A AU1785599 A AU 1785599A AU 17855/99 A AU17855/99 A AU 17855/99A AU 1785599 A AU1785599 A AU 1785599A AU 1785599 A AU1785599 A AU 1785599A
Authority
AU
Australia
Prior art keywords
pyrimidine derivatives
novel pyrimidine
novel
derivatives
pyrimidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU17855/99A
Inventor
Yoshitaka Araki
Yasuyuki Kawanishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of AU1785599A publication Critical patent/AU1785599A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69—Benzenesulfonamido-pyrimidines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU17855/99A 1998-01-19 1999-01-12 Novel pyrimidine derivatives Abandoned AU1785599A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP10-7445 1998-01-19
JP744598 1998-01-19
PCT/JP1999/000069 WO1999036408A1 (en) 1998-01-19 1999-01-12 Novel pyrimidine derivatives

Publications (1)

Publication Number Publication Date
AU1785599A true AU1785599A (en) 1999-08-02

Family

ID=11666049

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17855/99A Abandoned AU1785599A (en) 1998-01-19 1999-01-12 Novel pyrimidine derivatives

Country Status (3)

Country Link
JP (1) JP4433253B2 (en)
AU (1) AU1785599A (en)
WO (1) WO1999036408A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003518102A (en) * 1999-12-22 2003-06-03 アクテリオン ファマシューティカルズ リミテッド Butynediol derivative
AU2001263850A1 (en) * 2000-04-20 2001-11-07 Actelion Pharmaceuticals Ltd Pyrimidine-sulfonamides having endothelin-antagonist activity
US6387915B2 (en) 2000-05-31 2002-05-14 Pfizer Inc. Isoxazole-sulfonamide endothelin antagonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3734870B2 (en) * 1994-12-28 2006-01-11 興和株式会社 Pyrimidine derivatives and pharmaceuticals containing the same
JP3728028B2 (en) * 1995-09-06 2005-12-21 興和株式会社 Pyrimidine derivatives

Also Published As

Publication number Publication date
WO1999036408A1 (en) 1999-07-22
JP4433253B2 (en) 2010-03-17

Similar Documents

Publication Publication Date Title
AU5759999A (en) Pyrimidone derivatives
AU2897897A (en) Aryl pyrimidine derivatives
AU1151099A (en) Azaoxindole derivatives
AU2960599A (en) Quinazoline derivatives
AU1825899A (en) Dota-biotin derivatives
AU7935398A (en) Diaminorhodamine derivatives
AU6117998A (en) 3-oxadiazolylquinoxaline derivatives
AU4556700A (en) Pyrimidine compounds
AU5391099A (en) Substituted quinazoline derivatives
AU5429000A (en) Novel bicyclonucleoside derivatives
AU3706399A (en) Phosphodiesterase iv-inhibiting diazepinoindoles
AU3670000A (en) Novel thiazolobenzimidazole derivatives
AU1379900A (en) Novel substituted phenyloxazolidone derivatives
AU7813598A (en) Betulinol derivatives
AUPO863197A0 (en) Novel derivatives
AU1174199A (en) Biphenylamidine derivatives
AU6729498A (en) Thiazolimine derivatives
AU6228299A (en) 2-substituted-d-homooxasteroid derivatives
AU2275999A (en) Substituted guanidine derivatives
AU3467197A (en) Tetracyclical derivatives from pyrimidine
AU6115798A (en) Saponarin derivatives
AU1562199A (en) Amino-benzothiazole derivatives
AU2640999A (en) 1-azaindolizine derivatives
AU1785599A (en) Novel pyrimidine derivatives
AU4141099A (en) Pyrazolyldioxothiochromanoyl derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase